Filing Details

Accession Number:
0001209191-19-012978
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-25 16:19:47
Reporting Period:
2019-02-22
Accepted Time:
2019-02-25 16:19:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
19584 Chemed Corp CHE Services-Home Health Care Services (8082) 310791746
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1207134 S Spencer Lee 2500 Chemed Center
255 East 5Th Street
Cincinnati OH 45202
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Capital Stock Acquisiton 2019-02-22 1,206 $322.40 31,710 No 4 M Direct
Capital Stock Acquisiton 2019-02-22 854 $322.40 32,564 No 4 M Direct
Capital Stock Disposition 2019-02-22 917 $322.40 31,647 No 4 F Direct
Capital Stock Acquisiton 2019-02-25 12,500 $157.36 44,147 No 4 M Direct
Capital Stock Disposition 2019-02-25 9,098 $322.40 35,049 No 4 F Direct
Capital Stock Disposition 2019-02-25 3,514 $326.75 31,535 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Capital Stock stock option(right to buy with tandem tax withholding) Disposition 2019-02-25 12,500 $157.36 12,500 $157.36
Capital Stock performance stock units Disposition 2019-02-22 593 $0.00 593 $0.00
Capital Stock performance stock units Disposition 2019-02-22 593 $0.00 593 $0.00
Capital Stock performance stock units Acquisiton 2019-02-22 662 $0.00 662 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,600 2020-11-06 No 4 M Direct
2,385 No 4 M Direct
1,792 No 4 M Direct
2,454 No 4 A Direct
Footnotes
  1. The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2016 through December 31, 2018. The actual performance of 20.52% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 203.3% of target.
  2. The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2016 through December 31, 2018, compared to a defined peer group of companies. The Company's performance ranked in the 70th percentile of that group, yielding an award of 141.7%; including the reinvestment of dividends paid during such period, the award is 144.0% of target.
  3. Shares withheld to satisfy tax obligations in connection with vesting of PSU's.
  4. Payment of purchase price and tax obligation on stock option exercise.
  5. vesting in three equal annual installments commencing 11/6/2016.
  6. Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee.
  7. PSU's awarded February 22, 2016 vest based on achievement of performance targets over a period of January 1, 2016 to December 31, 2018. The determination of the performance level was to be made by March 15, 2019.
  8. Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock
  9. Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2019 to December 31, 2021. The determination of the performance level is to be made by March 15, 2022 and earned shares to be delivered thereafter